Visipaque 320 MG/ML bottle 100ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LD3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,304
Award facts
- Contract value 100% obligated
- $28,304.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $28,304.41 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company will perform work at its Conshohocken, PA location with an ultimate completion date of January 15, 2026.
Visipaque is a contrast agent used in diagnostic imaging procedures, making this delivery order part of AmerisourceBergen's comprehensive pharmaceutical supply portfolio to support military medical operations. The prime IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including products for specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen operates as a subsidiary of Cencora, Inc., which holds the master $999.999 billion IDC with DLA through December 31, 2031, demonstrating the parent organization's significant role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9LD3?
SPE2DR26F9LD3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F9LD3 worth?
The government has obligated $28,304 on SPE2DR26F9LD3.
Is contract SPE2DR26F9LD3 an order under another contract?
Yes. SPE2DR26F9LD3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LD3 competed?
The extent of competition for SPE2DR26F9LD3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award